Guardant Health (GH) PT Raised to $155 at BTIG
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Total darkness, then sunset as full eclipse wows spectators in Spain
Guardant Health (GH) PT Raised to $160 at BTIG, Second Day in a Row
May 27, 2026 12:49 PM EDTBTIG analyst Mark Massaro raised the price target on Guardant Health (NASDAQ: GH) to $160.00 (from $155.00) while maintaining a Buy rating.
Street Insider note: BTIG raised the PT yesterday to $155.00 from $145.00.The analyst comments "This morning, the American Cancer Society (ACS), a... More
